Los Angeles Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Los Angeles Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.54M	Sell	82,348 -22,107	-21%	-$414K	0.01%	508
2025 Q1	$1.88M	Buy	104,455 +18,454	+21%	+$332K	0.01%	411
2024 Q4	$1.45M	Buy	86,001 +11,499	+15%	+$193K	0.01%	517
2024 Q3	$1.21M	Buy	74,502 +19,094	+34%	+$309K	﹤0.01%	587
2024 Q2	$455K	Sell	55,408 -4,904	-8%	-$40.3K	﹤0.01%	884
2024 Q1	$893K	Buy	60,312 +19,871	+49%	+$294K	﹤0.01%	725
2023 Q4	$586K	Hold	40,441	–	–	﹤0.01%	823
2023 Q3	$437K	Buy	40,441 +94	+0.2%	+$1.02K	﹤0.01%	856
2023 Q2	$520K	Buy	40,347 +1,434	+4%	+$18.5K	﹤0.01%	845
2023 Q1	$514K	Sell	38,913 -1,246	-3%	-$16.4K	﹤0.01%	847
2022 Q4	$602K	Buy	40,159 +11,935	+42%	+$179K	﹤0.01%	843
2022 Q3	$333K	Buy	28,224 +3,781	+15%	+$44.6K	﹤0.01%	1042
2022 Q2	$276K	Sell	24,443 -710	-3%	-$8.02K	﹤0.01%	1171
2022 Q1	$752K	Hold	25,153	–	–	﹤0.01%	872
2021 Q4	$667K	Hold	25,153	–	–	﹤0.01%	880
2021 Q3	$913K	Sell	25,153 -2,358	-9%	-$85.6K	﹤0.01%	793
2021 Q2	$1.19M	Sell	27,511 -1,239	-4%	-$53.8K	0.01%	780
2021 Q1	$983K	Sell	28,750 -53,992	-65%	-$1.85M	﹤0.01%	901
2020 Q4	$2.9M	Sell	82,742 -11,397	-12%	-$399K	0.01%	544
2020 Q3	$2.26M	Buy	94,139 +34	+0%	+$816	0.01%	538
2020 Q2	$1.72M	Buy	94,105 +39,537	+72%	+$723K	0.01%	649
2020 Q1	$851K	Buy	54,568 +28,927	+113%	+$451K	0.01%	755
2019 Q4	$549K	Buy	25,641 +8,051	+46%	+$172K	﹤0.01%	992
2019 Q3	$329K	Hold	17,590	–	–	﹤0.01%	1101
2019 Q2	$459K	Hold	17,590	–	–	﹤0.01%	1069
2019 Q1	$452K	Hold	17,590	–	–	﹤0.01%	1110
2018 Q4	$405K	Sell	17,590 -1,893	-10%	-$43.6K	﹤0.01%	1019
2018 Q3	$625K	Buy	19,483 +7,090	+57%	+$227K	﹤0.01%	1038
2018 Q2	$351K	Buy	+12,393	New	+$351K	﹤0.01%	1243
2014 Q2	–	Sell	-16,131	Closed	-$626K	–	1274
2014 Q1	$626K	Buy	+16,131	New	+$626K	0.01%	798